Fulgent Genetics Inc (FLGT) reports a 16% increase in core revenue and expands market reach, despite facing GAAP losses and ...

Q2 2025 Earnings Call Transcript August 1, 2025 Fulgent Genetics, Inc. misses on earnings expectations. Reported EPS is $-0.62065 EPS, expectations were $-0.23. Operator: Greetings, and welcome to the ...

Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to earnings of $0.15 per share a ...

Fulgent Genetics ranks at the bottom for Revenue Growth and Gross Profit, with negative percentages. It is also at the bottom for Return on Equity, with a negative percentage. Overall, Fulgent ...

Fulgent Genetics, Inc. FLGT shares soared 6.6% in the last trading session to close at $23.31. The move was backed by solid volume with far more shares changing hands than in a normal session.

Get the cash flow statement for Fulgent Genetics, Inc. (FLGT). Up to 10 years of financial statements. Quarterly or annual. View as % YoY growth or as % of revenue.

Find the latest analyst research, reports, and ratings for Fulgent Genetics, Inc. Common Stock (FLGT) at Nasdaq.com.

Fulgent Genetics (FLGT) reported a better-than-expected Q4 earnings report. Read this article to know why FLGT stock remains a Buy.

FLGT is currently sporting a Zacks Rank of #1 (Strong Buy). The Zacks Consensus Estimate for FLGT's full-year earnings has moved 126.30% higher within the past quarter.